Quotient (Quotient) Days Sales Outstanding : 54.20 (As of Dec. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Quotient Days Sales Outstanding?

Quotient's average Accounts Receivable for the three months ended in Dec. 2022 was $5.91 Mil. Quotient's Revenue for the three months ended in Dec. 2022 was $9.95 Mil. Hence, Quotient's Days Sales Outstanding for the three months ended in Dec. 2022 was 54.20.

The historical rank and industry rank for Quotient's Days Sales Outstanding or its related term are showing as below:

QTNTQ's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 63.94
* Ranked among companies with meaningful Days Sales Outstanding only.

Quotient's Days Sales Outstanding increased from Dec. 2021 (49.99) to Dec. 2022 (54.20).

Quotient Days Sales Outstanding Historical Data

The historical data trend for Quotient's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quotient Days Sales Outstanding Chart

Quotient Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Days Sales Outstanding

Get a 7-Day Free Trial

39.98

38.90

48.90

45.12

54.94

Quotient Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Days Sales Outstanding	Get a 7-Day Free Trial															49.99	57.90	58.64	52.72	54.20

Competitive Comparison of Quotient's Days Sales Outstanding

For the Medical Devices subindustry, Quotient's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quotient's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Quotient's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Quotient's Days Sales Outstanding falls into.

Quotient Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Quotient's Days Sales Outstanding for the fiscal year that ended in Mar. 2022 is calculated as

	Days Sales Outstanding (A: Mar. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2021 )	+	Accounts Receivable (A: Mar. 2022 ))	/	count )	/	Revenue (A: Mar. 2022 )	*	Days in Period
=	( (5.323	+	6.272)	/	2 )	/	38.514	*	365
=	5.7975					/	38.514	*	365
=	54.94

Quotient's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding (Q: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (5.177	+	6.647)	/	2 )	/	9.954	*	365 / 4
=	5.912					/	9.954	*	365 / 4
=	54.20

Quotient (OTCPK:QTNTQ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Quotient Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Quotient's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Quotient (Quotient) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quotient Ltd (OTCPK:QTNTQ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Business Park Terre Bonne, Route de Crassier 13, Eysins, CHE, 1262

Website

https://www.quotientbd.com

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.

Executives

Highbridge Capital Management Llc	10 percent owner	277 PARK AVE, 23RD FLOOR, NEW YORK NY 10172
Quotient Holdings Finance Co Ltd	10 percent owner	C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, 71 FORT STREET, PO BOX 500, GRAND CAYMAN E9 KY1-1106
Quotient Holdings Newco, Lp	10 percent owner	C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON DE 19801
Quotient Holdings Merger Co Ltd	10 percent owner	PO BOX 536, 13-14 ESPLANADE, ST. HELIER Y9 JE4 5UR
Quotient Holdings Gp, Llc	10 percent owner	C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON DE 19801
Isabelle Buckle	director	C/O QUOTIENT LIMITED, B1, BUSINESS PARK, TERRE BONNE, ROUTE DE CRASSIER 13, EYSINS V8 1262
Prondzynski Heino Von	director	275 NORTH FIELD DRIVE, LAKE FOREST IL 60045
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Sophie Bechu	director	C/O QUOTIENT LIMITED, BUSINESS PARK TERRE BONNE, EYSINS V8 1262
Frederick Hallsworth	director	THE GARDEN WING, HOUSTON HOUSE, KIRK ROAD, HOUSTON X0 PA6 7AR
Manuel O. Mendez	director, officer: Chief Executive Officer	500 PLAZA DRIVE, SECAUCUS NJ 07094
L John Wilkerson	director, 10 percent owner	C/O GALEN ASSOCIATES, 610 FIFTH AVENUE 5TH FLOOR, NEW YORK NY 10020
Zubeen Shroff	director, 10 percent owner	C/O HALSEY DRUG CO INC, 1827 PACIFIC STREET, BROOKLYN NY 11233
Ali Kiboro	officer: Chief Financial Officer	C/O QUOTIENT LIMITED, B1, BUSINESS PARK TERRE BONNE, EYSINS V8 1262
Brian Mcdonough	director	12521 MARET DRIVE, ST. LOUIS MO 63127